Andrea Zivi

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Johann S. de Bono, Christopher J. Logothetis, Arturo Molina et al. · New England Journal of Medicine · 2011 · 4.4K citations · Full text

Medicine, Oncology, Pharmacology +17

Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?

Janusz Mezynski, Carmel Pezaro, Diletta Bianchini et al. · Annals of Oncology · 2012 · 248 citations

Medicine, Oncology, Pharmacology +16

Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone

Diletta Bianchini, David Lorente, Alejo Rodríguez‐Vida et al. · European Journal of Cancer · 2013 · 209 citations

Medicine, Oncology, Pharmacology +14

Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations

Sabine Schmid, Aurelius Omlin, Celestia S. Higano et al. · JAMA Network Open · 2020 · 113 citations · Full text

Medicine, Oncology, Urology +14

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer

Diletta Bianchini, Aurelius Omlin, Carmel Pezaro et al. · British Journal of Cancer · 2013 · 91 citations · Full text

Medicine, Oncology, Pharmacology +17